Study On Financial Performance Under Asset-light Strategy For Hengrui Medicine Co.Ltd

With the improvement of our country's market economy and the intensification of the internationalization process,the environment faced by enterprises is becoming more and more complex.Under this background,the operating mode chosen by the enterprises can determine the value of an enterprise and adjust its own It is particularly important that the business model is adapted to change.Enterprises should achieve rapid growth and sustained competitiveness.They should not blindly rely on equipment and fixed assets to expand their production capacity and scale,but should also attach importance to "Asset-light" such as brand,marketing,patent,intellectual property and management and enhance their core competitiveness.With the improvement of people's life,the public nowadays pay more and more attention to medical treatment,which has a bright future for the pharmaceutical manufacturing industry.At the same time,the lack of innovative ability and backward management in the pharmaceutical manufacturing industry in China restrict the development of the enterprises.The impact is also increasing,how to improve the business model to improve business value has become a cross in front of enterprises problems.This paper first sorts out the relevant literature and theory on Asset-light strategy,analyzes that as Asset-light enterprise with emphasis on R & D and management in the pharmaceutical manufacturing industry,HENGRUI Pharmaceutical analyzed its important data from 2011 to 2016,financial indicators and From the analysis of economic value added,this paper analyzes the success stories of HENGRUI Pharmaceutical's Asset-light operation mode that enable enterprises to continuously profit,enhance their core competitiveness and raise the corporate value from aspects of research and development,assets operation,marketing and cash flow management.By comparing with peers,HENGRUI Pharmaceutical further confirmed the superiority of Asset-light strategy and demonstrated that HENGRUI Medical Asset-light strategy can bring value to shareholders.Through the above research,I hope to enrich the pharmaceutical manufacturing industry in Asset-light strategy,and hope that through the case of HENGRUImedicine Co.ltd,for other pharmaceutical manufacturing or to improve the mode of operation of some enlightenment to promote the healthy development of the pharmaceutical industry.